
Keywords: 5-HT1A; serotonin 1A receptor; AE; adverse events; AIDS; acquired immunodeficiency syndrome; CB1; cannabinoid-one receptor; CB2; cannabinoid-two receptor; CBD; cannabidiol; CBDA; cannabidiolic acid; CRISP-R; Clustered Regularly Interspaced Short Palindrom